Results 31 to 40 of about 189,601 (408)

Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

Clinical Cancer Research, 2020
Purpose: Emerging evidence indicates that gut microbiota dysbiosis can reduce the effectiveness of immune checkpoint inhibitors (ICI). Proton pump inhibitors (PPI) are known to induce gut microbiota changes.
A. Hopkins, G. Kichenadasse, C. Karapetis, A. Rowland, M. Sorich   +4 more
semanticscholar   +1 more source

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease [PDF]

, 2016
Background Acute interstitial nephritis secondary to proton pump inhibitors (PPIs) frequently goes undiagnosed due to its subacute clinical presentation, which may later present as chronic kidney disease (CKD).
Arora, Pradeep, Carter, Randolph L., Golzy, Mojgan, Gupta, Anu, Jalal, Kabir, Lohr, James W., Patel, Nilang   +6 more
core   +2 more sources

Proton Pump Inhibitors

World Chinese Journal of Digestology, 2013
Proton pump inhibitors (PPIs), omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, and dexlansoprazole bind irreversibly to the H+, K+- ATPase (the “proton pump”) inhibiting its activity and decreasing gastric acid production.
Nghia H. Pham, Brian A. Baldo
openaire   +4 more sources

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors

eJHaem, 2020
Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj   +1 more source

Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study [PDF]

, 2011
Background and objective: Gastro-oesophageal reflux has been implicated in the pathogenesis of chronic cough. Guidelines on management suggest a therapeutic trial of anti-reflux medication.
Beecher, Belafsky, Birring, Blondeau, Chang, Corley, Decalmer, DeVault, Dial, Eccles, Eherer, Everett, Faruqi, FitzGerald, Gilard, Gulmez, Hemmink, Herzig, Ing, Irwin, Irwin, Irwin, Irwin, Juurlink, Laheij, Lenglinger, Mastronarde, Morice, Morice, Morice, Morice, Noordzij, Pratter, Rostami-Hodjegan, Shaheen, Vaezi, Vertigan, Wager, Waring, Wo, Yang, Yearsley   +41 more
core   +1 more source

Structures and proton-pumping strategies of mitochondrial respiratory enzymes [PDF]

, 2001
Enzymes of the mitochondrial respiratory chain serve as proton pumps, using the energy made available from electron transfer reactions to transport protons across the inner mitochondrial membrane and create an electrochemical gradient used for the ...
Chan, Sunney I., Schultz, Brian E.
core   +1 more source

Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers

BMC Geriatrics, 2022
Background Proton pump inhibitors, benzodiazepines, and antipsychotics are considered potentially inappropriate medications in older adults according to the American Geriatric Society Beers Criteria, and deprescribing algorithms have been developed to ...
Jennifer M. Toth, Saumil Jadhav, Holly M. Holmes, Manvi Sharma   +3 more
doaj   +1 more source

The Role of Esophageal PH-metri Test on Gastro-Esophageal Reflux Disease Diagnosis [PDF]

, 2008
Gastro-esophageal reflux disease is a pathological condition of esophagus which is caused by gastric content reflux into esophagus. There is an increased prevalence of gastro-esophageal reflux disease.
Abdullah, M. (Murdani), Fauzi, A. (Achmad), Makmun, D. (Dadang), Manan, C. (Chudahman), Rani, A. A. (Abdul), Setyawati, K. (Katharina), Simadibrata, M. (Marcellus), Syam, A. F. (Ari)   +7 more
core   +1 more source

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy

BMC Gastroenterology, 2012
Background High dose intravenous proton pump inhibitor after endoscopic therapy for peptic ulcer bleeding has been recommended as adjuvant therapy.
Yen Hsu-Heng, Yang Chia-Wei, Su Wei-Wen, Soon Maw-Soan, Wu Shun-Sheng, Lin Hwai-Jeng   +5 more
doaj   +1 more source

Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.

Gastroenterology, 2019
BACKGROUND & AIMS There are few data on the prevalence of gastroesophageal reflux disease (GERD) in the United States. We performed a population-based study to determine the prevalence of GERD symptoms and persistent GERD symptoms despite use of proton ...
Sean D. Delshad, Christopher V. Almario, W. Chey, B. Spiegel   +3 more
semanticscholar   +1 more source